BOSTON SCIENTIFIC CORP is 37.0x more valuable than NovoCure Ltd by market capitalization ($71.33 B vs $1.93 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | NVCR | BSX |
|---|---|---|
| Market cap | $1.93 B | $71.33 B |
| US-listed rank | #2120 | #239 |
| Revenue (latest FY) | $655.35M | $20.07B |
| Net income (latest FY) | -$136.23M | - |
| Net margin | -20.8% | - |
| SEC filings | 1,138 | 1,009 |
BOSTON SCIENTIFIC CORP is 37.0x more valuable than NovoCure Ltd by market capitalization ($71.33 B vs $1.93 B).
In their latest fiscal years, NovoCure Ltd reported $655.35M in revenue while BOSTON SCIENTIFIC CORP reported $20.07B.
Full pages: NovoCure Ltd and BOSTON SCIENTIFIC CORP, or browse the full rankings.